ReviewFrontiers in immunology2026

Tislelizumab plus chemotherapy followed by anlotinib maintenance therapy in a patient with extensive-stage small cell lung cancer and intracranial recurrence after palliative whole-brain radiotherapy: a case report and literature review.

Rong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.